Edwards Lifesciences Corp (EW)vsXtant Medical Holdings Inc (XTNT)
EW
Edwards Lifesciences Corp
$82.67
+1.20%
HEALTHCARE · Cap: $48.01B
XTNT
Xtant Medical Holdings Inc
$0.56
+0.55%
HEALTHCARE · Cap: $81.52M
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 4459% more annual revenue ($6.07B vs $133.08M). EW leads profitability with a 17.7% profit margin vs 1.3%. XTNT appears more attractively valued with a PEG of 1.74. EW earns a higher WallStSmart Score of 55/100 (C).
EW
Buy55
out of 100
Grade: C
XTNT
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-544.4%
Fair Value
$12.31
Current Price
$82.67
$70.36 premium
Margin of Safety
-744.3%
Fair Value
$0.07
Current Price
$0.56
$0.49 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 23.7%
Reasonable price relative to book value
19.0% revenue growth
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Earnings declined 76.6%
Expensive relative to growth rate
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 3.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 23.7%. Revenue growth of 13.3% demonstrates continued momentum.
Bull Case : XTNT
The strongest argument for XTNT centers on Price/Book, Revenue Growth. Revenue growth of 19.0% demonstrates continued momentum.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 45.7x leaves little room for execution misses.
Bear Case : XTNT
The primary concerns for XTNT are PEG Ratio, EPS Growth, Market Cap. A P/E of 58.2x leaves little room for execution misses. Thin 1.3% margins leave little buffer for downturns.
Key Dynamics to Monitor
EW profiles as a mature stock while XTNT is a growth play — different risk/reward profiles.
EW carries more volatility with a beta of 0.93 — expect wider price swings.
XTNT is growing revenue faster at 19.0% — sustainability is the question.
EW generates stronger free cash flow (354M), providing more financial flexibility.
Bottom Line
EW scores higher overall (55/100 vs 50/100), backed by strong 17.7% margins and 13.3% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Xtant Medical Holdings Inc
HEALTHCARE · MEDICAL DEVICES · USA
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?